Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

IsraCann Biosciences, Inc. Cannabis Stock

IsaCann Biosciences, Inc.

IsraCann Biosciences, Inc. (ISCNF) is Israel’s first pure-play cannabis company. They grow outside Tel Aviv and are trying to produce low cost cannabis for exportation into Europe. ISCNF cannabis stock is listed on the OTC markets and are headquartered in Vancouver, Canada.

Is ISCNF a strong BUY and HOLD?

IsraCann Biosciences Fundamental Analysis

Profile

HQ: Vancouver, BC, Canada
Founded: 2010
Facilities: Tel Aviv, Israel
Symbol: ISCNF (OTC), IPOT (CSE)

Focus: Strong

IsraCann is an Israeli firm focused on cultivation. They’re targeting outdoor grows to utilize the ground and sun in Israel to attempt to make low cost cannabis for export into Europe.

They are targeting production costs of only $0.40 per gram (compared to an average of $1.50 per gram in Canada). 

Size: Weak

Market Cap: US $24.27 mil
Enterprise Value: US $21.75 mil
# of employees: 3

Markets: Strong

Primary: Israel
Secondary: Europe starting with Germany
Majority Subsidiaries:   Cannisra crops Ltd, Isracann Holdings Inc, The Cranium
 

Operations: Neutral

Cultivation:
Current production: They have a JV  with 55,000 sq ft
Future capacity:  The JV can grow to 160,000 sq ft in greenhouses with lots of outdoor land available to them. Their own facility will be 230,000 sq ft and have capacity of 23,500 kg per year.

Israel was the 3rd country to develop an export framework for cannabis (behind Canada and the Netherlands). They will use this to their advantage and supply Europe with their low cost cannabis.

Israel has 46,000 medical patients with 90,000 anticipated by year’s end. 

Distribution:
Direct sales: Yes
Store networks: None

Integration/Diversification: 
Vertically integrated: Yes
Horizontally diversified: No

Financials: Weak

2020 Revenue (ttm): $310,346
Outstanding shares (diluted): 135 mil
Return on Equity: -116%

Management: Weak

President, CEO, Director: Darryl Jones
CFO: Yana Popova
COO: Matt Chatterton

Management experience includes investment advising, project management, and accounting.

Branding: Neutral

They will rely heavily on the “made in Israel” brand with a focus on quality. Both cannabis for export as well as CBD products will be explored. Low cost, lots of sun, and good soil are all benefits of growing in Israel.

Valuation: Neutral

Current share price: US $0.1748
Price to Sales: 8.83 (Tobacco industry = 5)
52 week low/high: US $0.0908- $0.549
EV/Revenue: 54.02
Price/book: 1.21

Financing: Weak

After Q3 2020 (August 31st, 2020) they had $3 million of working capital. They raised about $150k through warrants and options. The company has around $1 million in debt.

ISCNF Technical Analysis

Should I buy IsraCann Biosciences?

Follow Stephen Goldman as he evaluates IsraCann Biosciences (ISCNF) using different moving averages, the Aroon Up/Down, and the stochastic RSI.

Remember sound cannabis stock trading strategies include both Fundamental Analysis and Technical Analysis.

/
Day Range -
52 Week Range -
Market Cap
Shares Traded
Volume

Bottom Line: Is IsraCann Biosciences Cannabis Stock a Buy?

Recommendation: Neutral (for now)

IsraCann Biosciences, Inc. is a cannabis cultivator in Israel. They are striving to become a low cost cultivator, which will give them an advantage in exporting their products to Germany and eventually all of the EU.

IsraCann has been slightly delayed in planting their first crop and blame covid-19 as well as licensing. The good news is that the Israeli government has approved rules for export of cannabis. This export will occur at a fixed price of CAD $5.50 per gram. If they are indeed able to produce cannabis at $0.40 per gram there would be fantastic profit margins in supplying the EU with smokable cannabis.

Locally the Israeli market is growing too. With an estimated 200,000 patients consuming an estimated 85 tonnes per year, there should be plenty of demand locally. Although they have no revenue yet from cannabis related businesses, they do have promise. They just need to get that first crop planted.

The company reported losses of $838,792 during the three months ending August 31st, 2020. This is compared to new losses of $894,848 in 2019. They have around $3 million in working capital so they can fund most of 2021 now. Without significant revenue after that from cultivating they will need to raise funds.

We generally like this company, although the management team is slightly inexperienced. If they can have a few successful harvests and export to Germany, there will be revenue to drive stock prices higher. This is at least 5-6 months away however. For the short term, this is rated Neutral but watch it long term for this to switch to Strong.

If you are looking for more productive cannabis companies, check out our Featured Companies Page for many other winners in the cannabis and hemp industry.

Symbol Name Last Price Change % Change
Algorithmic Stock Trading Hemp Stocks

Can Hemp Become a Mainstream Component in the Automotive Industry?

The automotive industry has been researching how to introduce hemp and other fiber into their production process for close to eighty years. In 1941 Henry Ford built a prototype of a car made almost entirely of bio-plastic and was to be fueled by hemp ethanol. These...

4 Hot Hemp Stocks to Buy Now

As we enter the second quarter of 2021, investors are becoming more aware of the fact that the hemp industry is booming. It was valued at $5 billion last year and it is estimated to reach more than $24 billion by 2026. Cannabis and hemp stock investors understand the...

Is Microdosing Psychedelics Good for You?

If you have been following the trends lately, you might have noticed a considered increase in the number of people microdosing on psychedelics regularly. Several stories have come out about how Silicon Valley entrepreneurs microdose on psychedelics regularly and how...

Trulieve: When to Buy or Sell this Cannabis Stock

Fundamentally, Trulieve should be one of the best cannabis stocks to buy - but what does the technical analysis tell us? Let's dive into Trulieve and when to buy or sell this cannabis stock. Trulieve Cannabis (OTC: TCNNF) continues to grow steadily and now holds a 52%...

Cannin’s Top 5 Psychedelic Stocks for 2021

For several years, investors have been excited about the emergence and growth potential of cannabis stocks. What started as unabated enthusiasm for cannabis stocks has now calmed to strategic patience. Currently, many investors are waiting for the cannabis industry to...

How is Patagonia Creating a Domestic Supply Chain for Hemp Fiber?

The Hemp fiber industry continues to grow at an incredible rate. In fact, the fiber is one of the primary sources of fiber for large-scale manufacturing. This is because hemp fiber is both biodegradable and eco-friendly - its also more durable and versatile than...